Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer

Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...
ukrmedia

Alyona alyona has announced that she has had gastric bypass surgery

The rapper spoke about her conscious decision to undergo bariatric surgery, the first few days of her recovery and her ...

Obesity treatment: Can new weight-loss drugs really replace bariatric surgery? Here's what a bariatric surgeon explains

New weight-loss drugs and bariatric surgery are crucial for obesity treatment, enhancing metabolic health and aiding ...